• We offer tailored partnerships to support and transform drug discovery.

    Every collaboration is a bespoke arrangement, meticulously designed to discover new compounds and targets in patient relevant disease models.

  • MIMETAS offers flexible fee-for-service solutions for therapy prioritization, optimization, and de-risking of compounds.

    As an extension of your team, MIMETAS provides the expertise and resources needed for effective research and development.

  • Our OrganoReady program is made for you when you need optimized assays for investigational toxicology.

    We guarantee OrganoReady performance according to specifications, in a fast and convenient sales transaction with a clear fee structure.

  • Giving you some food for thought. Read our blogs to learn more about 3D tissue culture, research backgrounds, developments, and its future outlook.
  • Get inspired by research done by our scientists, partners, and customers around the globe.

  • Learn about our mission, vision, the history of the company, and find out what we mean with MIMETAS-do.
open menu icon close menu icon
EN

MPS World Summit 2025

June 9 - 13, Brussels, Belgium


The MPS World Summit brings together over 40 international organizations and companies to advance the field of microphysiological systems (MPS). These systems, which replicate human organ function in vitro, are transforming biomedical research through innovations in stem-cell technology and bioengineering.

This annual conference series serves as a critical platform for global collaboration, knowledge exchange, and scientific harmonization. By connecting established experts with early-career researchers, the Summit fosters a vibrant community dedicated to driving innovation and shaping the future of MPS technologies.


Meet us at Booth #416 and join us at the following activities:

Oral Presentations:

  • Unidirectional, pumpless, scalable: Perfusable vascular networks with long-term stability using a gravity driven microfluidic system
    Theme 1: MPS Development and Results Processing: 1.5 Leveraging physiology with vascularization and immune-competence.​ ​
    Thursday June 12, 14:30 - 16:30,​ Time: 15:00 - 15:20

  • An automated and multiplexed liver fibrosis screening assay on a microfluidic liver model that replicates the cellular composition and organization of the hepatic lobule
    Theme 3: MPS for Efficacy, ADME and Toxicity Testing: 3.6 Drug discovery for precision medicine
    Friday June 13th 08:30 - 10:30​, Time: 09:20 - 09:40

 

Poster Presentations:

  • An immunocompetent human kidney on-a-chip model to study renal inflammation and immune-mediated injury
    Session 2: Wednesday June 11 Afternoon (16:30 – 18:00)
    Poster 179

  • Automated toxicology screening in a microfluidic, assay-ready adult stem cell-derived colon organoid model for evaluating therapy-induced gastrointestinal toxicity
    Session 3: Thursday June 12 Morning (10:00 – 11:30)
    Poster 186

  • CAR-T migration and cytotoxicity in a vessel-cancer co-culture
    Session 4: Thursday June 12, Afternoon (16:30 – 18:00)
    Poster 175

  • Targeting HCC tumor microenvironment interactions using an advanced HCC patient-derived on-chip model
    Session 4: Thursday June 12, Afternoon (16:30 – 18:00)
    Poster 181

 

Schedule a meeting with us

 

Link to the conference homepage

Cookies

May we use cookies?
Hi there! Thanks for visiting our website. We use cookies to keep track of our website statistics to optimize the user experience. We also use cookies for marketing purposes. You can set your preferences by selecting the options below. Terms of Use & Privacy Policy
Accept all
Accept selected
Decline all